Literature DB >> 16037552

Treatment of verruca plantaris with a combination of topical fluorouracil and salicylic acid.

Simon Young1, Greg E Cohen.   

Abstract

A medical record review was conducted to determine the clinical outcome and average time to resolution of verruca plantaris in 20 patients treated with twice-daily applications of either 0.5% or 5.0% topical fluorouracil combined with topical 17% and 40% salicylic acid. Seven patients used 0.5% fluorouracil, and 13 used 5.0% fluorouracil. All of the lesions were sharply debrided at regular 1- or 2-week intervals. All 20 patients achieved full clinical resolution in a mean +/- SD of 82.5 +/- 56.6 days. Three patients (15%) had recurrent lesions, which subsequently resolved with repeated treatment. Two patients (10%) developed local dermatitis, which resolved with temporary discontinuation of the medication and the addition of a topical corticosteroid. It was observed that the twice-daily application of topical fluorouracil and salicylic acid is a safe and effective treatment for verruca plantaris.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16037552     DOI: 10.7547/0950366

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  4 in total

Review 1.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

2.  Allergic contact dermatitis of adjacent normal skin from 5-fluorouracil for the treatment of flat facial warts.

Authors:  Usman Asad; Jeannie Nguyen; Ashley Sturgeon
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-10-17

3.  Effectiveness of New 5-Fluorouracil/Salicylic Acid Application Method for Periungual Warts: A Descriptive Study.

Authors:  Do-Yeop Kim; Hyunsun Park; Soyun Cho; Hyun-Sun Yoon
Journal:  Ann Dermatol       Date:  2020-06-30       Impact factor: 1.444

4.  Efficacy of the Treatment of Plantar Warts Using 1064 nm Laser and Cooling.

Authors:  Elena de Planell-Mas; Blanca Martínez-Garriga; Miguel Viñas; Antonio J Zalacain-Vicuña
Journal:  Int J Environ Res Public Health       Date:  2022-01-12       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.